GROMACS version: 2019
GROMACS modification: No
Hello all.
My aim is, model a bilayer membrane from CHARMM-GUI, equilibrate the asymmetric mixed bilayer and use the final frame for drug-membrane interactions studies. As of now, the first step is done, and now drug-membrane interactions studies.
Issue 1: PBC-centered membrane structure has lipid tails projections, out of the PBC box. I added the drug and increased the box size in the Z direction alone (6.60073 X 6.60073 X 11 nm^3). [XY dimensions are taken from the previous equilibration step and preserved the same]. Deleting those lipid molecules seems not good because there are only 25 LipidA are in the upper leaflet and it will affect the similar surface area in the upper and lower leaflet. Or if I increase the box size in XY direction, water will be there on either side of lipid tail projections, but the literature never mentioned such a water padding method (as per my knowledge). Are these projections are normal or allowed? I hope it will create issues during tpr generation and energy minimization if I keep the same. How to solve this?
Issue 2: As per Researchgate answers, I increased the “C” vdw radius (temporarily) during solvation, so that water will not be placed inside the bilayer hydrophobic packing. Is it a proper way to perform during the solvation to avoid water permeation? If this is acceptable, what is the proper “C” vdw radii to consider, avoiding dehydration?
Kindly provide me your valuable suggestions.
Thanks for reading.